Propylparaben Powder
NDC Package 51552-0102-7

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.
This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Propylparaben powders is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a powder delivery system. Marketed by Fagron Inc, this product is identified by NDC 51552-0102.

Identification & Billing

NDC Package Code
51552-0102-7
Package Description
500 g in 1 CONTAINER
Product Code
51552-0102
11-Digit Billing Format
51552010207

Clinical Specifications

Proprietary Name
Propylparaben
Non-Proprietary Name
Propylparaben
Substance Name
Propylparaben
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
PROPYLPARABEN 1 g/g

Regulatory & Marketing

Labeler Name
Fagron Inc
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING - A category specifying that a bulk product is intended for use on humans and requires a prescription.
Start Marketing Date
04-01-1998
End Marketing Date
06-30-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51552-0102-7 identifies a specific commercial package of 500 g in 1 container of Propylparaben (UNFINISHED drug), a bulk ingredient labeled by Fagron Inc. This powder is formulated for use and contains propylparaben as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fagron Inc on April 01, 1998.

How is this Fagron Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51552010207. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51552-0102-7
11-Digit CMS (5-4-2)
51552-0102-07

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.